There’s currently no reliable screening test for ovarian cancer, meaning that most cases are caught at an advanced stage, ...

Removing the fallopian tubes during routine gynecological surgery reduced the risk of serous ovarian cancer by nearly 80%.

You might hear about your risk of ovarian cancer through an aunt, mother, sister or grandmother. For some, there are no signs of hereditary cancer in the family, but genetic testing still reveals a ...

A preventative surgical procedure developed in British Columbia appears to drastically reduce a woman’s risk of developing the most common and deadly form of ovarian cancer, a merciless disease of ...

A new ovarian cancer surveillance test is now being offered to women with an inherited risk of the disease, marking a significant development in care. University College London Hospitals NHS ...

Separate facts and misconceptions about ovarian cancer to help better prevent and manage the disease.

Sept. 12 -- FRIDAY, Sept. 11 (HealthDay News) -- The U.S. Food and Drug Administration has approved a new test for women with pelvic tumors that are known to need surgery. The test, called OVA1, will ...

Blood-based circulating tumor DNA (ctDNA) testing has proven to be insufficient for detecting KRAS mutations in patients with low-grade serous ovarian cancer (LGSOC), according to a study. The ...

Ovarian cancer kills more women than any other gynecological cancer. Most patients receive their diagnosis only after the ...

Treatment with relacorilant plus Abraxane (nab-paclitaxel) may offer a broader option for patients with platinum-resistant ...

Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.

Experts debate MMR/p53 testing, liquid biopsy, and immunotherapy sequencing in endometrial cancer, refining prognosis and relapse treatment.